AI acne diagnosis means software that grades acne photos. A 105-study scoping review shows teledermatology patients still need clinician review to stay safe. A scoping review maps what studies exist rather than testing one product. Teledermatology means skin care through photos and messages, where a treatment choice still needs a clinician.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 105 studies tested
- Who the models may miss
- Can AI help an online acne visit?
- How to use acne tools safely
What the 105 studies tested
The International Journal of Dermatology review searched PubMed, Cochrane and Scopus and kept 105 articles on diagnosis and management, according to the scoping review in the International Journal of Dermatology. Dermatology Times reporting on the review notes 101 studies covered diagnosis only. Ten covered management only and six covered both.
Most tools read photos. Dermatology Times summarizing the review reports deep learning in 76.2% of studies. Deep learning means layers that learn patterns from images, and ensemble models averaged 89.7% diagnostic accuracy.
Who the models may miss
Dermatology Times also reports only about 13% of studies listed skin color or ethnicity, in its summary of the November review. Under 4% used skin-tone data when building models.
In a 1,117-case skin-lesion test, Dermatology Times reporting on JAMA Dermatology notes senior dermatologists reached 74.2% accuracy and beat AI. AI matched mid-career clinicians and beat novices, so skill level still changes results.
Can AI help an online acne visit?
For teledermatology cases, JAMA Network Open found AI help raised agreement for 40 primary-care clinicians across 1,048 cases, as described in the JAMA Network Open study. Improvement touched about one in every eight to ten cases.
In a 2026 real-world rollout described by MedicalXpress, a CE-marked device discharged 25 to 31% of urgent referrals as benign. Higher-risk cases still went to a teledermatologist, which let clinicians catch AI misses.
How to use acne tools safely
No consumer app claiming to diagnose skin disease has FDA approval, the American Academy of Dermatology warns in its app safety notice. Treat app labels as guesses, not diagnoses.
Use AI as prep for your visit. Share clear facts so the clinician can judge fast.
- Send sharp photos in daylight, front and side, without filters.
- List current products, prescriptions, and how long you used each.
- Flag pain, rapid spread, scarring, dark marks, or no change after care.
You Might Also Like
- Artificial Intelligence for Acne Diagnosis in a 2026 Scoping Review: Privacy and Photo-Data Questions for Teledermatology Patients
- What 105 Studies Reveal About Acne AI in the 2026 Review: Privacy and Photo-Data Questions for Teledermatology Patients
- Acne AI Validation and Clinical Safety Questions in 2026: Privacy and Photo-Data Questions for Teledermatology Patients